The next board meeting for Revance Therapeutics Inc is on 01 Apr 2025 for the purpose of Revance Therapeutics Inc Annual General Meeting for 2025See details
Revance Therapeutics Inc has a share price target of US$ 8, revenue growth forecast of 12.6%, and profit growth estimate of 48.0% for FY24, based on top 8 analyst calls.